These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. What people expect you to know about poison ivy. Beyea SC RN; 1989 Aug; 52(8):23-5. PubMed ID: 2532390 [No Abstract] [Full Text] [Related]
4. A murine model system for contact sensitization to poison oak or ivy urushiol components. Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516 [No Abstract] [Full Text] [Related]
5. Poison ivy/oak dermatitis. Part I: Prevention--soap and water, topical barriers, hyposensitization. Fisher AA Cutis; 1996 Jun; 57(6):384-6. PubMed ID: 8804839 [No Abstract] [Full Text] [Related]
6. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis. Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the contact allergenicity of the four pentadecylcatechols derived from poison ivy urushiol in human subjects. Johnson RA; Haer H; Kirkpatrick CH; Dawson CR; Khurana RG J Allergy Clin Immunol; 1972 Jan; 49(1):27-35. PubMed ID: 4257103 [No Abstract] [Full Text] [Related]
8. What methods are effective to prevent or treat poison ivy/oak/sumac? McGuffey EC Am Pharm; 1993 May; NS33(5):18. PubMed ID: 8333401 [No Abstract] [Full Text] [Related]
9. Perfluorinated analogues of poison ivy allergens. Synthesis and skin tolerogenic activity in mice. Fraginals R; Schaeffer M; Stampf JL; Benezra C J Med Chem; 1991 Mar; 34(3):1024-7. PubMed ID: 1825847 [TBL] [Abstract][Full Text] [Related]
10. Poison ivy, oak, and sumac dermatitis. Lee NP; Arriola ER West J Med; 1999; 171(5-6):354-5. PubMed ID: 10639874 [No Abstract] [Full Text] [Related]
11. Is it, or isn't it? Poison ivy look-a-likes. McGovern TW; LaWarre SR; Brunette C Am J Contact Dermat; 2000 Jun; 11(2):104-10. PubMed ID: 10908180 [TBL] [Abstract][Full Text] [Related]
12. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates. Dupuis G Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173 [TBL] [Abstract][Full Text] [Related]
13. [Toxic contact dermatitis from poison ivy in a private garden in Germany]. Schauder S; Callauch R; Hausen BM Hautarzt; 2006 Jul; 57(7):618-21. PubMed ID: 15834598 [TBL] [Abstract][Full Text] [Related]
14. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed. Long D; Ballentine NH; Marks JG Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283 [TBL] [Abstract][Full Text] [Related]
15. Delayed contact sensitivity to catechols. 3. The relationship of side-chain length to sensitizing potency of catechols chemically related to the active principles of poison ivy. Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR J Immunol; 1967 Aug; 99(2):370-5. PubMed ID: 4226616 [No Abstract] [Full Text] [Related]
16. Induction of tolerance to poison ivy urushiol in the guinea pig by epicutaneous application of the structural analog 5-methyl-3-n-pentadecylcatechol. Stampf JL; Benezra C; Byers V; Castagnoli N J Invest Dermatol; 1986 May; 86(5):535-8. PubMed ID: 2943824 [TBL] [Abstract][Full Text] [Related]
17. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs. Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903 [TBL] [Abstract][Full Text] [Related]
18. [Contact eczema by jobo (Spandia magnifera) in a Northamerican patient allergic to poison ivy]. Negreiros B Alergia; 1979 Jul; 26(3):115-20. PubMed ID: 158991 [No Abstract] [Full Text] [Related]